AAAAAA
Results: 326-350/15678
Authors:
Falck-Ytter, Y
McCullough, AJ
Citation: Y. Falck-ytter et Aj. Mccullough, The risks of percutaneous liver biopsy, HEPATOLOGY, 33(3), 2001, pp. 764-764
Authors:
te Morsche, RHM
Zusterzeel, PLM
Raijmakers, MTM
Roes, EM
Steegers, EAP
Peters, WHM
Citation: Rhm. Te Morsche et al., Polymorphism in the promoter region of the bilirubin UDP-glucuronosyltransferase (Gilbert's syndrome) in healthy Dutch subjects, HEPATOLOGY, 33(3), 2001, pp. 765-765
Authors:
Orland, JR
Wright, TL
Cooper, S
Citation: Jr. Orland et al., Acute hepatitis C, HEPATOLOGY, 33(2), 2001, pp. 321-327
Authors:
Miquel, JF
van der Putten, J
Pimentel, F
Mok, KS
Groen, AK
Citation: Jf. Miquel et al., Increased activity in the biliary Con A-binding fraction accounts for the difference in crystallization behavior in bile from Chilean gallstone patients compared with Dutch gallstone patients, HEPATOLOGY, 33(2), 2001, pp. 328-332
Authors:
Schepis, F
Camma, C
Niceforo, D
Magnano, A
Pallio, S
Cinquegrani, M
D'Amico, G
Pasta, L
Craxi, A
Saitta, A
Raimondo, G
Citation: F. Schepis et al., Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?, HEPATOLOGY, 33(2), 2001, pp. 333-338
Authors:
Nagy, P
Teramoto, T
Factor, VM
Sanchez, A
Schnur, J
Paku, S
Thorgeirsson, SS
Citation: P. Nagy et al., Reconstitution of liver mass via cellular hypertrophy in the rat, HEPATOLOGY, 33(2), 2001, pp. 339-345
Authors:
Murphy, D
Detjen, KM
Welzel, M
Wiedenmann, B
Rosewicz, S
Citation: D. Murphy et al., Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases, HEPATOLOGY, 33(2), 2001, pp. 346-356
Authors:
Ueno, Y
Moriyama, M
Uchida, T
Arakawa, Y
Citation: Y. Ueno et al., Irregular regeneration of hepatocytes is an important factor in the hepatocarcinogenesis of liver disease, HEPATOLOGY, 33(2), 2001, pp. 357-362
Authors:
Wack, KE
Ross, MA
Zegarra, V
Sysko, LR
Watkins, SC
Stolz, DB
Citation: Ke. Wack et al., Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver, HEPATOLOGY, 33(2), 2001, pp. 363-378
Authors:
Bruck, R
Genina, O
Aeed, H
Alexiev, R
Nagler, A
Avni, Y
Pines, M
Citation: R. Bruck et al., Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats, HEPATOLOGY, 33(2), 2001, pp. 379-386
Authors:
Breitkopf, K
Lahme, B
Tag, CG
Gressner, AM
Citation: K. Breitkopf et al., Expression and matrix deposition of latent transforming growth factor betabinding proteins in normal and fibrotic rat liver and transdifferentiatinghepatic stellate cells in culture, HEPATOLOGY, 33(2), 2001, pp. 387-396
Authors:
Gujral, JS
Bucci, TJ
Farhood, A
Jaeschke, H
Citation: Js. Gujral et al., Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: Apoptosis or necrosis?, HEPATOLOGY, 33(2), 2001, pp. 397-405
Authors:
Sinclair, PR
Gorman, N
Walton, HS
Bement, WJ
Sinclair, JF
Gerhard, GS
Szakacs, JG
Andrews, NC
Levy, JE
Citation: Pr. Sinclair et al., Uroporphyria in HFE mutant mice given 5-aminolevulinate: A new model of Fe-mediated porphyria cutanea tarda, HEPATOLOGY, 33(2), 2001, pp. 406-412
Authors:
Milliano, MT
Luxon, BA
Citation: Mt. Milliano et Ba. Luxon, The peroxisomal proliferator clofibrate enhances the hepatic cytoplasmic movement of fatty acids in rats, HEPATOLOGY, 33(2), 2001, pp. 413-418
Authors:
Bekkering, FC
Stalgis, C
McHutchison, JG
Brouwer, JT
Perelson, AS
Citation: Fc. Bekkering et al., Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model, HEPATOLOGY, 33(2), 2001, pp. 419-423
Authors:
Perrillo, RP
Wright, T
Rakela, J
Levy, G
Schiff, E
Gish, R
Martin, P
Dienstag, J
Adams, P
Dickson, R
Anschuetz, G
Bell, S
Condreay, L
Brown, N
Citation: Rp. Perrillo et al., A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis, HEPATOLOGY, 33(2), 2001, pp. 424-432
Authors:
Reddy, KR
Wright, TL
Pockros, PJ
Shiffman, M
Everson, G
Reindollar, R
Fried, MW
Purdum, PP
Jensen, D
Smith, C
Lee, WM
Boyer, TD
Lin, A
Pedder, S
DePamphilis, J
Citation: Kr. Reddy et al., Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared withinterferon alpha-2a in noncirrhotic patients with chronic hepatitis C, HEPATOLOGY, 33(2), 2001, pp. 433-438
Authors:
Nakamura, I
Nupp, JT
Cowlen, M
Hall, WC
Tennant, BC
Casey, JL
Gerin, JL
Cote, PJ
Citation: I. Nakamura et al., Pathogenesis of experimental neonatal woodchuck hepatitis virus infection:Chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor-alpha messenger RNAs, HEPATOLOGY, 33(2), 2001, pp. 439-447
Authors:
Pancholi, P
Lee, DH
Liu, QY
Tackney, C
Taylor, P
Perkus, M
Andrus, L
Brotman, B
Prince, AM
Citation: P. Pancholi et al., DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virusinfection in a chimpanzee, HEPATOLOGY, 33(2), 2001, pp. 448-454
Authors:
Seeff, LB
Hollinger, FB
Alter, HJ
Wright, EC
Cain, CMB
Buskell, ZJ
Ishak, KG
Iber, FL
Toro, D
Samanta, A
Koretz, RL
Perrillo, RP
Goodman, ZD
Knodell, RG
Gitnick, G
Morgan, TR
Schiff, ER
Lasky, S
Stevens, C
Vlahcevic, RZ
Weinshel, E
Tanwandee, T
Lin, HJ
Barbosa, L
Citation: Lb. Seeff et al., Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A national heart, lung, and blood institute collaborative study, HEPATOLOGY, 33(2), 2001, pp. 455-463
Authors:
Kamath, PS
Wiesner, RH
Malinchoc, M
Kremers, W
Therneau, TM
Kosberg, CL
D'Amico, G
Dickson, ER
Kim, WR
Citation: Ps. Kamath et al., A model to predict survival in patients with end-stage liver disease, HEPATOLOGY, 33(2), 2001, pp. 464-470
Authors:
Fleig, WE
Citation: We. Fleig, To scope or not to scope: Still a question, HEPATOLOGY, 33(2), 2001, pp. 471-472
Authors:
Forman, LM
Lucey, MR
Citation: Lm. Forman et Mr. Lucey, Predicting the prognosis of chronic liver disease: An evolution from childto MELD, HEPATOLOGY, 33(2), 2001, pp. 473-475
Authors:
Denson, LA
Citation: La. Denson, Got bile?, HEPATOLOGY, 33(2), 2001, pp. 476-477
Authors:
Garcia-Tsao, G
Citation: G. Garcia-tsao, Treatment of refractory ascites: Tips or taps?, HEPATOLOGY, 33(2), 2001, pp. 477-479